American Bio Medica back in compliance with Nasdaq standards

New York, Sept. 30 - American Bio Medica Corp. said it has regained compliance with the Nasdaq Stock Market's listing requirements.

The Kinderhook, N.Y., biotechnology company said Nasdaq told it on Friday that it meets the listing standards because its stock closed at $1.00 per share or higher for at least 10 consecutive business days.

American Bio Medica had been warned on April 27 that it was at risk of being delisted because its stock had closed below $1.00 per share for 30 consecutive business days.

American Bio Medica makes immunoassay diagnostic test kits, including for drug abuse.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.